We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TOYO:NASDAQTOYO Co., Ltd Analysis

Data as of 2026-06-17 - not real-time

$12.34

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

TOYO trades at a trailing P/E of 6.3 versus an industry average of 37.2, delivering an extreme value gap that translates to an estimated upside of roughly 34%. Margins are robust – gross margin sits near 27% and operating margin above 25% – while ROE is an eye‑catching 70%, indicating efficient capital use. The balance sheet shows modest leverage (debt‑to‑equity ~84%) with cash covering a third of total debt, and forward earnings are projected to more than double the trailing EPS, supporting a forward P/E of just 3.0. Despite a volatile 30‑day price swing exceeding 120%, beta under 1 and an increasing volume trend suggest the stock is not overly market‑sensitive and liquidity is adequate.
Technical indicators paint a mixed picture: the stock is below its 20‑day SMA but remains above the 200‑day SMA, and the MACD histogram is negative, hinting at short‑term pressure. However, the broader trend remains bullish, and the current price sits comfortably above the identified support level of 11.74. With the “Extreme Greed” sentiment on the Fear & Greed Index and a modest overall risk score, the profile leans toward a strategic entry point, especially for investors seeking value with upside potential in the growing solar sector.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near technical support
  • negative MACD histogram
  • high short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • substantial valuation discount
  • strong operating margins and ROE
  • projected earnings acceleration

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • structural growth in solar demand
  • strategic expansion in U.S. market
  • sustainable cash flow generation

Key Metrics & Analysis

Financial Health

Revenue Growth177.00%
Profit Margin13.75%
P/E Ratio6.3
ROE69.55%
Debt/Equity83.52
P/B Ratio4.1
Op. Cash Flow$162.7M
Industry P/E37.2

Technical Analysis

TrendBullish
RSI43.6
Support$11.74
Resistance$17.43
MA 20$14.39
MA 50$12.95
MA 200$8.52
MACDBearish
VolumeIncreasing
Fear & Greed Index92.13

Valuation

Fair Value$107.31
Target Price$16.50
Upside/Downside33.71%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.90
Volatility123.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.